Current medicines are the product of clinical research that has often used somewhat subjective clinical endpoints. However, the newest generation of targeted therapies requires new development tools that provide more objective measures of therapeutic response. Today’s imaging biomarkers are starting to address that need.
With its unique history, experience, and resources within medical imaging, INVIA is ideally positioned to provide imaging services as a contract research organization (CRO). Our mission is to deliver quantitative and accurate results in support of clinical research.
Click on any of the below links to learn more about our services, or click here to contact an INVIA imaging scientist.
